Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
March 11, 2015 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on March 9, 2015, the Compensation Committee of the Company's Board of Directors...
Raptor Pharmaceutical to Observe International Rare Disease Day Through Global Awareness Programs
February 23, 2015 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its support of Rare Disease Day on February 28, 2015 with a series of initiatives and events...
Raptor Pharmaceutical to Attend Upcoming Investor Conferences
February 18, 2015 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Michael Smith, Chief Financial Officer will participate in the following investor...
PROCYSBI(R) to Receive New Treatment Award From Lysosomal Disease Network at the 11th Annual WORLD Symposium
February 10, 2015 09:51 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Lysosomal Disease Network (LDN) will present Raptor Pharmaceutical with the 2015...
Raptor Pharmaceutical to Present at the 2015 Leerink Global Healthcare Conference
January 30, 2015 13:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will present at the following conference:
Julie Anne Smith, President and Chief...
Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 20, 2015 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on January 15, 2015, a majority of the independent members of the Company's Board of...
Raptor Pharmaceutical Appoints Krishna Polu, M.D. as Chief Medical Officer and Michael Smith as Chief Financial Officer
January 07, 2015 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Krishna R. Polu, M.D., as its Chief Medical Officer and Michael P. Smith...
Raptor Pharmaceutical Appoints Gregg Lapointe and Georges Gemayel to Board of Directors
December 18, 2014 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Gregg Lapointe and Georges Gemayel, Ph.D. to its Board of Directors,...
Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 01, 2014 09:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on November 25, 2014, as a key requirement of the Company's strategy of strengthening...
Raptor Pharmaceutical to Present at the 26th Annual Piper Jaffray Healthcare Conference
November 18, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will participate in the following conference:
Julie Anne Smith,...